May 20, 2014
Dr. Fernando Martinez, the newly appointed Executive Vice Chair of Medicine, Weill Cornell Department of Medicine, has published new findings in The New England Journal of Medicine on N-acetylcysteine (NAC), a widely used antioxidant for treating deadly lung disease. Along with senior author Dr. Ganesh Raghu and other colleagues, the 264-patient study determined that there is no evidence that NAC slowed the progression of idiopathic pulmonary fibrosis (IPF) or improved lung function.